United Therapeutics Corp (UTHR) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The companys products consist of prostacyclin analogues including Remodulin (treprostinil) injection and Tyvaso (treprostinil) inhalation solution; and Orenitram (treprostinil). Adcirca (tadalafil) is a phosphodiesterase type 5 (PDE-5) inhibitor and Unituxin (dinutuximab) is used for monoclonal antibody for oncologic applications are the other products. Its product candidates include monoclonal antibodies (mAbs), glycobiology antiviral agents and cell-based therapies. The company also develops engineered lungs for transplantation in pre-clinical stage. It manufactures its products in its facility in Silver Spring, Maryland. It operates in the US and markets its products across Europe, South America and Israel. UTC is headquartered in Silver Spring, Maryland, the US.

United Therapeutics Corp (UTHR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
United Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
United Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 11
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Celularity Raises USD250 Million in Venture Financing 14
Celularity Raises Funds through Series A Financing 16
Partnerships 17
United Therapeutics Enters into Licensing Agreement with Respira Therapeutics 17
Sorrento Therapeutics, Celgene, United Therapeutics and Human Longevity Forms Joint Venture 18
Mochida Pharma Enters into Distribution Agreement with United Therapeutics 19
Northwell Health Enters into Partnership with United Therapeutics 20
Grupo Ferrer and Pint Pharma Enter into Distribution Agreement with United Therapeutics 21
United Therapeutics Enters into Agreement with DEKA Research & Development 22
Synthetic Genomics Expands R&D Agreement with Lung Biotech 23
Licensing Agreements 24
United Therapeutics Enters into Licensing Agreement with Corsair Pharma 24
Equity Offering 25
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 25
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 26
Acquisition 27
United Therapeutics to Acquire SteadyMed for USD216 Million 27
United Therapeutics Acquires Minority Stake in Corsair Pharma 29
United Therapeutics May Sell Itself 30
Emergent BioSolutions Acquires Unither Virology from United Therapeutics 31
United Therapeutics Corp - Key Competitors 32
United Therapeutics Corp - Key Employees 33
United Therapeutics Corp - Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 36
Financial Announcements 36
Feb 21, 2018: United Therapeutics Reports 2017 Fourth Quarter And Annual Financial Results 36
Oct 25, 2017: United Therapeutics Reports Third Quarter 2017 Financial Results 38
Jul 27, 2017: United Therapeutics Reports Second Quarter 2017 Financial Results 40
Apr 26, 2017: United Therapeutics Reports First Quarter 2017 Financial Results 42
Feb 22, 2017: United Therapeutics Reports 2016 Fourth Quarter And Annual Financial Results 43
Legal and Regulatory 44
Mar 31, 2017: SteadyMed Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent 44
Product News 45
10/23/2017: United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso Inhalation System 45
Aug 21, 2017: Celularity Accelerates Breakthrough Placental Discovery & Therapeutic Platform 46
04/03/2017: United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List Of Tables

List of Tables
United Therapeutics Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
United Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
United Therapeutics Corp, Deals By Therapy Area, 2012 to YTD 2018 9
United Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 11
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Celularity Raises USD250 Million in Venture Financing 14
Celularity Raises Funds through Series A Financing 16
United Therapeutics Enters into Licensing Agreement with Respira Therapeutics 17
Sorrento Therapeutics, Celgene, United Therapeutics and Human Longevity Forms Joint Venture 18
Mochida Pharma Enters into Distribution Agreement with United Therapeutics 19
Northwell Health Enters into Partnership with United Therapeutics 20
Grupo Ferrer and Pint Pharma Enter into Distribution Agreement with United Therapeutics 21
United Therapeutics Enters into Agreement with DEKA Research & Development 22
Synthetic Genomics Expands R&D Agreement with Lung Biotech 23
United Therapeutics Enters into Licensing Agreement with Corsair Pharma 24
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 25
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 26
United Therapeutics to Acquire SteadyMed for USD216 Million 27
United Therapeutics Acquires Minority Stake in Corsair Pharma 29
United Therapeutics May Sell Itself 30
Emergent BioSolutions Acquires Unither Virology from United Therapeutics 31
United Therapeutics Corp, Key Competitors 32
United Therapeutics Corp, Key Employees 33
United Therapeutics Corp, Other Locations 34
United Therapeutics Corp, Subsidiaries 34

List Of Figures

List of Figures
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
United Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
United Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 11

United BioPharma Inc (6471) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

United BioPharma Inc (United BioPharma) is a pharmaceutical company. The company develops, manufactures, and markets monoclonal antibody (mAb) products and biosimilar antibodies. Its molecules product pipeline includes UB-421, a monoclonal

USD 250 View Report

Movies and Entertainment in the United Kingdom

Movies & Entertainment in the United KingdomMovies & Entertainment in the United Kingdom industry profile provides top-line qualitative and quantitative information including: market size (value 2013-17, and forecast to

USD 350 View Report

Centrexion Therapeutics Corp - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Centrexion Therapeutics Corp (Centrexion Therapeutics), formerly Centrexion Corp is a developer of clinical pipelines of novel and non opioid chronic pain therapy products. The company offers products such as CNTX-4975,

USD 250 View Report

United Therapeutics: Performance, Capabilities, Goals and Strategies in the Global Biotechnology Market

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation

USD 950 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available